ANIP logo

ANI Pharmaceuticals (ANIP) Cash from operations

annual CFO:

$64.02M-$54.94M(-46.19%)
December 31, 2024

Summary

  • As of today (May 21, 2025), ANIP annual cash flow from operations is $64.02 million, with the most recent change of -$54.94 million (-46.19%) on December 31, 2024.
  • During the last 3 years, ANIP annual CFO has risen by +$60.70 million (+1827.06%).
  • ANIP annual CFO is now -46.19% below its all-time high of $118.96 million, reached on December 31, 2023.

Performance

ANIP Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

quarterly CFO:

$34.99M+$19.13M(+120.62%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP quarterly cash flow from operations is $34.99 million, with the most recent change of +$19.13 million (+120.62%) on March 31, 2025.
  • Over the past year, ANIP quarterly CFO has increased by +$16.72 million (+91.53%).
  • ANIP quarterly CFO is now -21.79% below its all-time high of $44.74 million, reached on December 31, 2023.

Performance

ANIP quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

TTM CFO:

$80.74M+$16.72M(+26.12%)
March 31, 2025

Summary

  • As of today (May 21, 2025), ANIP TTM cash flow from operations is $80.74 million, with the most recent change of +$16.72 million (+26.12%) on March 31, 2025.
  • Over the past year, ANIP TTM CFO has dropped by -$35.06 million (-30.28%).
  • ANIP TTM CFO is now -32.13% below its all-time high of $118.96 million, reached on December 31, 2023.

Performance

ANIP TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherANIPcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ANIP Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-46.2%+91.5%-30.3%
3 y3 years+1827.1%+284.7%+322.5%
5 y5 years+40.3%+1946.3%+144.3%

ANIP Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-46.2%+305.2%-21.8%+284.7%-32.1%+268.2%
5 y5-year-46.2%+305.2%-21.8%+284.7%-32.1%+268.2%
alltimeall time-46.2%+233.7%-21.8%+284.7%-32.1%+257.9%

ANIP Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$34.99M(+120.6%)
$80.74M(+26.1%)
Dec 2024
$64.02M(-46.2%)
$15.86M(+27.1%)
$64.02M(-31.1%)
Sep 2024
-
$12.47M(-28.4%)
$92.90M(-17.5%)
Jun 2024
-
$17.41M(-4.7%)
$112.59M(-2.8%)
Mar 2024
-
$18.27M(-59.2%)
$115.80M(-2.7%)
Dec 2023
$118.96M(-481.2%)
$44.74M(+39.1%)
$118.96M(+70.4%)
Sep 2023
-
$32.17M(+56.0%)
$69.82M(+69.2%)
Jun 2023
-
$20.63M(-3.7%)
$41.27M(+350.4%)
Mar 2023
-
$21.42M(-586.9%)
$9.16M(-129.4%)
Dec 2022
-$31.20M(-1039.3%)
-$4.40M(-221.4%)
-$31.20M(-20.0%)
Sep 2022
-
$3.62M(-131.5%)
-$38.99M(-18.8%)
Jun 2022
-
-$11.48M(-39.4%)
-$48.01M(+32.3%)
Mar 2022
-
-$18.94M(+55.5%)
-$36.29M(-1192.4%)
Dec 2021
$3.32M(-78.2%)
-$12.19M(+125.6%)
$3.32M(-66.1%)
Sep 2021
-
-$5.40M(-2341.5%)
$9.80M(-27.9%)
Jun 2021
-
$241.00K(-98.8%)
$13.59M(-60.3%)
Mar 2021
-
$20.67M(-462.0%)
$34.23M(+124.2%)
Dec 2020
$15.27M(-66.5%)
-$5.71M(+253.7%)
$15.27M(-40.8%)
Sep 2020
-
-$1.61M(-107.7%)
$25.78M(-47.6%)
Jun 2020
-
$20.88M(+1121.1%)
$49.19M(+48.8%)
Mar 2020
-
$1.71M(-64.4%)
$33.05M(-27.6%)
Dec 2019
$45.63M(-32.0%)
$4.80M(-78.0%)
$45.63M(-33.0%)
Sep 2019
-
$21.79M(+359.4%)
$68.06M(+24.7%)
Jun 2019
-
$4.74M(-66.8%)
$54.59M(-6.6%)
Mar 2019
-
$14.29M(-47.5%)
$58.44M(-12.9%)
Dec 2018
$67.07M(+70.2%)
$27.23M(+227.3%)
$67.07M(+20.5%)
Sep 2018
-
$8.32M(-3.2%)
$55.65M(-13.6%)
Jun 2018
-
$8.59M(-62.5%)
$64.41M(+15.4%)
Mar 2018
-
$22.93M(+45.1%)
$55.82M(+41.6%)
Dec 2017
$39.42M(+43.5%)
$15.80M(-7.5%)
$39.42M(+10.4%)
Sep 2017
-
$17.08M(>+9900.0%)
$35.70M(+81.2%)
Jun 2017
-
$1000.00(-100.0%)
$19.70M(-14.5%)
Mar 2017
-
$6.53M(-46.0%)
$23.03M(-16.2%)
Dec 2016
$27.47M(+59.1%)
$12.08M(+1014.6%)
$27.47M(+36.7%)
Sep 2016
-
$1.08M(-67.5%)
$20.09M(-31.3%)
Jun 2016
-
$3.34M(-69.6%)
$29.24M(+7.9%)
Mar 2016
-
$10.97M(+133.3%)
$27.11M(+57.0%)
Dec 2015
$17.26M(-21.6%)
$4.70M(-54.1%)
$17.26M(-25.9%)
Sep 2015
-
$10.24M(+748.8%)
$23.30M(+35.3%)
Jun 2015
-
$1.21M(+7.7%)
$17.23M(-4.2%)
Mar 2015
-
$1.12M(-89.6%)
$17.97M(-18.4%)
Dec 2014
$22.03M(-501.8%)
$10.74M(+158.3%)
$22.03M(+161.5%)
Sep 2014
-
$4.16M(+112.8%)
$8.43M(+219.6%)
Jun 2014
-
$1.95M(-62.3%)
$2.64M(-31.3%)
Mar 2014
-
$5.18M(-280.8%)
$3.84M(-170.0%)
Dec 2013
-$5.48M(-78.3%)
-$2.87M(+75.7%)
-$5.48M(-5.2%)
Sep 2013
-
-$1.63M(-151.7%)
-$5.78M(-49.9%)
Jun 2013
-
$3.16M(-176.2%)
-$11.53M(-46.9%)
Mar 2013
-
-$4.15M(+31.0%)
-$21.74M(-14.0%)
Dec 2012
-$25.28M
-$3.16M(-57.1%)
-$25.28M(-23.5%)
Sep 2012
-
-$7.38M(+4.8%)
-$33.04M(-13.6%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$7.05M(-8.4%)
-$38.24M(-15.2%)
Mar 2012
-
-$7.69M(-29.6%)
-$45.09M(-5.8%)
Dec 2011
-$47.87M(+19.4%)
-$10.93M(-13.2%)
-$47.87M(-6.4%)
Sep 2011
-
-$12.58M(-9.4%)
-$51.15M(+3.5%)
Jun 2011
-
-$13.89M(+32.6%)
-$49.42M(+11.3%)
Mar 2011
-
-$10.47M(-26.3%)
-$44.41M(+10.8%)
Dec 2010
-$40.10M(+117.6%)
-$14.20M(+30.9%)
-$40.10M(+25.2%)
Sep 2010
-
-$10.85M(+22.2%)
-$32.03M(+28.6%)
Jun 2010
-
-$8.88M(+44.1%)
-$24.91M(+23.7%)
Mar 2010
-
-$6.16M(+0.4%)
-$20.13M(+9.2%)
Dec 2009
-$18.43M(+18.6%)
-$6.14M(+64.6%)
-$18.43M(+24.9%)
Sep 2009
-
-$3.73M(-9.2%)
-$14.75M(-13.0%)
Jun 2009
-
-$4.11M(-7.9%)
-$16.96M(-3.3%)
Mar 2009
-
-$4.46M(+81.4%)
-$17.54M(+12.9%)
Dec 2008
-$15.54M(-2199.4%)
-$2.46M(-58.6%)
-$15.54M(+31.9%)
Sep 2008
-
-$5.93M(+26.7%)
-$11.78M(+48.7%)
Jun 2008
-
-$4.68M(+90.4%)
-$7.92M(+50.1%)
Mar 2008
-
-$2.46M(-289.8%)
-$5.28M(-813.0%)
Dec 2007
$740.00K(-114.8%)
$1.30M(-162.6%)
$739.90K(+18.7%)
Sep 2007
-
-$2.07M(+1.6%)
$623.40K(-53.8%)
Jun 2007
-
-$2.04M(-157.4%)
$1.35M(+59.0%)
Mar 2007
-
$3.56M(+201.3%)
$848.30K(-117.0%)
Dec 2006
-$5.00M(-39.8%)
$1.18M(-187.6%)
-$5.00M(-32.0%)
Sep 2006
-
-$1.35M(-47.0%)
-$7.35M(-5.5%)
Jun 2006
-
-$2.54M(+10.9%)
-$7.78M(-2.0%)
Mar 2006
-
-$2.29M(+94.6%)
-$7.94M(-4.3%)
Dec 2005
-$8.30M(-20.5%)
-$1.18M(-33.6%)
-$8.30M(-21.9%)
Sep 2005
-
-$1.77M(-34.4%)
-$10.62M(-8.3%)
Jun 2005
-
-$2.70M(+2.0%)
-$11.58M(+2.9%)
Mar 2005
-
-$2.65M(-24.4%)
-$11.26M(+7.8%)
Dec 2004
-$10.44M(+89.1%)
-$3.50M(+28.3%)
-$10.44M(+25.5%)
Sep 2004
-
-$2.73M(+14.8%)
-$8.32M(+15.8%)
Jun 2004
-
-$2.38M(+29.7%)
-$7.19M(+22.2%)
Mar 2004
-
-$1.83M(+32.6%)
-$5.88M(+6.5%)
Dec 2003
-$5.52M(+39.4%)
-$1.38M(-13.3%)
-$5.52M(+23.9%)
Sep 2003
-
-$1.59M(+48.4%)
-$4.46M(+17.8%)
Jun 2003
-
-$1.07M(-27.0%)
-$3.78M(-8.0%)
Mar 2003
-
-$1.47M(+364.6%)
-$4.11M(+3.8%)
Dec 2002
-$3.96M(+117.3%)
-$316.80K(-65.6%)
-$3.96M(-21.1%)
Sep 2002
-
-$920.30K(-34.4%)
-$5.02M(+63.7%)
Jun 2002
-
-$1.40M(+6.2%)
-$3.07M(+30.0%)
Mar 2002
-
-$1.32M(-3.8%)
-$2.36M(+29.4%)
Dec 2001
-$1.82M(-42.1%)
-$1.37M(-233.1%)
-$1.82M(+81.8%)
Sep 2001
-
$1.03M(-248.3%)
-$1.00M(-63.2%)
Jun 2001
-
-$696.10K(-11.4%)
-$2.73M(-21.5%)
Mar 2001
-
-$785.70K(+41.9%)
-$3.47M(+10.3%)
Dec 2000
-$3.15M(+76.2%)
-$553.60K(-20.0%)
-$3.15M(+21.3%)
Sep 2000
-
-$692.00K(-52.0%)
-$2.60M(+36.3%)
Jun 2000
-
-$1.44M(+212.9%)
-$1.90M(+312.9%)
Mar 2000
-
-$461.20K
-$461.20K
Dec 1999
-$1.79M(-41.2%)
-
-
Dec 1998
-$3.04M
-
-

FAQ

  • What is ANI Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual CFO year-on-year change?
  • What is ANI Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly CFO year-on-year change?
  • What is ANI Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals TTM CFO year-on-year change?

What is ANI Pharmaceuticals annual cash flow from operations?

The current annual CFO of ANIP is $64.02M

What is the all time high annual CFO for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual cash flow from operations is $118.96M

What is ANI Pharmaceuticals annual CFO year-on-year change?

Over the past year, ANIP annual cash flow from operations has changed by -$54.94M (-46.19%)

What is ANI Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of ANIP is $34.99M

What is the all time high quarterly CFO for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly cash flow from operations is $44.74M

What is ANI Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, ANIP quarterly cash flow from operations has changed by +$16.72M (+91.53%)

What is ANI Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of ANIP is $80.74M

What is the all time high TTM CFO for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high TTM cash flow from operations is $118.96M

What is ANI Pharmaceuticals TTM CFO year-on-year change?

Over the past year, ANIP TTM cash flow from operations has changed by -$35.06M (-30.28%)
On this page